Market revenue in 2022 | USD 386.4 million |
Market revenue in 2030 | USD 673.0 million |
Growth rate | 7.2% (CAGR from 2022 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Clinical |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical, Pre-clinical |
Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.45% in 2022. Horizon Databook has segmented the Saudi Arabia lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia’s economy is highly impacted by the food and beverages industry. A high standard of living and an increase in disposable income of the population is driving customers to consume processed food. The population prefers ready-to-eat food items over traditional food as it is available for immediate consumption and can be preserved efficiently.
The change in lifestyles of the consumer and adoption of luxury life is leaving less time for cooking food and driving them toward ready-to-eat food, which, in turn, is driving the processed food market. This would affect the demand for lipids in the country. Saudi Arabia's pharmaceutical market dominates in the Middle East and African region.
According to the Pharmaceuticals Export Promotion Council of India report, Saudi Arabian drug spending accounts for 54.4% of the country’s total drug market. Higher drug production is expected to boost the demand for lipids in the region.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia lipid market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account